Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 1 for:    NCT00004992
Previous Study | Return to List | Next Study

Diabetes Prevention Program Identifier:
First received: March 17, 2000
Last updated: February 3, 2011
Last verified: February 2011

March 17, 2000
February 3, 2011
July 1996
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00004992 on Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Diabetes Prevention Program
Not Provided

The Diabetes Prevention Program is a nationwide clinical study to answer the question: Can Type 2 diabetes (also called noninsulin-dependent or adult-onset diabetes) be prevented or delayed? The study has recruited 3819 volunteers, who are at high risk of developing diabetes, at twenty-five medical centers in the United States. It is sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, and other Institute and corporate sponsors. Researchers will evaluate the efficacy of a lifestyle intervention and a pharmacological intervention in preventing or delaying Type 2 diabetes in persons with IGT, impaired glucose tolerance. Each person in the study will be followed for 3 to 6 years.

Not Provided
Not Provided
Allocation: Randomized
Masking: Double-Blind
Primary Purpose: Prevention
  • Diabetes Mellitus, Non-Insulin-Dependent
  • Glucose Intolerance
Behavioral: Intensive lifestyle
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
April 2001
Not Provided

Inclusion Criteria:

  • Impaired glucose tolerance (FPG 95-125 mg/dL and 2hr PG 140-199 mg/dL)
  • BMI >= 24 kg/m2

Exclusion Criteria:

  • Underlying disease likely to limit life span and/or increase risk of interventions
  • Conditions or behaviors likely to effect conduct of the DPP
  • Diabetes or disordered glucose metabolism
  • Suboptimally treated Thyroid disease
  • Fasting triglyceride level < 600 mg/dl
  • Exclusions related to medications
Not Provided
Contact information is only displayed when the study is recruiting subjects
United States
(IND) - DPP (completed), DK48489
Not Provided
Not Provided
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • National Institute on Aging (NIA)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • National Center on Minority Health and Health Disparities (NCMHD)
  • Office of Research on Women's Health (ORWH)
Principal Investigator: Sarah Fowler, PhD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
February 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP